Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

SEPSIS 3 Critera for Risk Stratification in Emergency Patients (SCREEN)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02738164
Recruitment Status : Completed
First Posted : April 14, 2016
Last Update Posted : July 19, 2016
Sponsor:
Information provided by (Responsible Party):
Societe Française de Medecine d'urgence

Brief Summary:

Investigators aim to evaluate the SEPSIS 3 criterion for "sepsis" and "septic shock" in a prospective manner.

Investigators will evaluate qSOFA performances and other SEPSIS 3 criterion in a population of emergency patients with infection


Condition or disease
Sepsis Emergency

Layout table for study information
Study Type : Observational
Actual Enrollment : 879 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Validation of the SEPSIS-3 Criterion for Sepsis and Septic Shock in the Emergency Department
Study Start Date : May 2016
Actual Primary Completion Date : July 2016
Actual Study Completion Date : July 2016

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Sepsis




Primary Outcome Measures :
  1. In hospital mortality [ Time Frame: 30 days ]

Secondary Outcome Measures :
  1. admission in ICU [ Time Frame: 30 days ]
  2. length of ICU stay more than 72 hours [ Time Frame: 30 days ]
  3. Length of hospital stay [ Time Frame: 30 days ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Emergency patients with infection
Criteria

Inclusion Criteria:

  • Adult that present to the emergency department
  • Diagnosis of infection by the treating emergency physician

Exclusion Criteria:

  • Refuse to participate
  • pregnancy
  • prisoner
  • Low acuity infection (localised, not requiring general treatment, without any abnormal vital parameters)

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02738164


Locations
Show Show 27 study locations
Sponsors and Collaborators
Societe Française de Medecine d'urgence
Investigators
Layout table for investigator information
Principal Investigator: Yonathan Freund, MD, PhD SFMU

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Societe Française de Medecine d'urgence
ClinicalTrials.gov Identifier: NCT02738164    
Other Study ID Numbers: SCREEN_SFMU
First Posted: April 14, 2016    Key Record Dates
Last Update Posted: July 19, 2016
Last Verified: July 2016
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided
Additional relevant MeSH terms:
Layout table for MeSH terms
Sepsis
Toxemia
Emergencies
Disease Attributes
Pathologic Processes
Infection
Systemic Inflammatory Response Syndrome
Inflammation